139 related articles for article (PubMed ID: 27914864)
1. Serum DHEA-S concentration correlates with clinical symptoms and neurocognitive function in patients with bipolar II disorder: A case-controlled study.
Lee SY; Wang LJ; Chang CH; Wu CC; Chen HL; Lin SH; Chu CL; Lu T; Lu RB
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Mar; 74():31-35. PubMed ID: 27914864
[TBL] [Abstract][Full Text] [Related]
2. Gender differences in susceptibility to schizophrenia: Potential implication of neurosteroids.
Huang YC; Hung CF; Lin PY; Lee Y; Wu CC; Hsu ST; Chen CC; Chong MY; Lin CH; Wang LJ
Psychoneuroendocrinology; 2017 Oct; 84():87-93. PubMed ID: 28686904
[TBL] [Abstract][Full Text] [Related]
3. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls.
Kurita H; Maeshima H; Kida S; Matsuzaka H; Shimano T; Nakano Y; Baba H; Suzuki T; Arai H
J Affect Disord; 2013 Apr; 146(2):205-12. PubMed ID: 23102506
[TBL] [Abstract][Full Text] [Related]
4. Serum dehydroepiandrosterone, dehydroepiandrosterone sulfate, and pregnenolone sulfate concentrations in patients with hyperthyroidism and hypothyroidism.
Tagawa N; Tamanaka J; Fujinami A; Kobayashi Y; Takano T; Fukata S; Kuma K; Tada H; Amino N
Clin Chem; 2000 Apr; 46(4):523-8. PubMed ID: 10759476
[TBL] [Abstract][Full Text] [Related]
5. Lowered DHEA-S plasma levels in adult individuals with autistic disorder.
Strous RD; Golubchik P; Maayan R; Mozes T; Tuati-Werner D; Weizman A; Spivak B
Eur Neuropsychopharmacol; 2005 May; 15(3):305-9. PubMed ID: 15820420
[TBL] [Abstract][Full Text] [Related]
6. Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: a randomized, double-blind placebo controlled trial.
Strous RD; Stryjer R; Maayan R; Gal G; Viglin D; Katz E; Eisner D; Weizman A
Psychoneuroendocrinology; 2007 Feb; 32(2):96-105. PubMed ID: 17208382
[TBL] [Abstract][Full Text] [Related]
7. Neurocognitive deficits in schizophrenia are associated with alterations in blood levels of neurosteroids: a multiple regression analysis of findings from a double-blind, randomized, placebo-controlled, crossover trial with DHEA.
Ritsner MS; Strous RD
J Psychiatr Res; 2010 Jan; 44(2):75-80. PubMed ID: 19665142
[TBL] [Abstract][Full Text] [Related]
8. Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder.
Gallagher P; Watson S; Smith MS; Young AH; Ferrier IN
Schizophr Res; 2007 Feb; 90(1-3):258-65. PubMed ID: 17222537
[TBL] [Abstract][Full Text] [Related]
9. The relationship between longitudinal declines in dehydroepiandrosterone sulfate concentrations and cognitive performance in older men.
Moffat SD; Zonderman AB; Harman SM; Blackman MR; Kawas C; Resnick SM
Arch Intern Med; 2000 Jul; 160(14):2193-8. PubMed ID: 10904463
[TBL] [Abstract][Full Text] [Related]
10. Plasma dehydroepiandrosterone sulfate levels in patients with major depressive disorder correlate with remission during treatment with antidepressants.
Morita T; Senzaki K; Ishihara R; Umeda K; Iwata N; Nagai T; Hida H; Nabeshima T; Yukawa K; Ozaki N; Noda Y
Hum Psychopharmacol; 2014 May; 29(3):280-6. PubMed ID: 24911578
[TBL] [Abstract][Full Text] [Related]
11. Three-month treatment course of methylphenidate increases plasma levels of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) in attention deficit hyperactivity disorder.
Maayan R; Yoran-Hegesh R; Strous R; Nechmad A; Averbuch E; Weizman A; Spivak B
Neuropsychobiology; 2003; 48(3):111-5. PubMed ID: 14586159
[TBL] [Abstract][Full Text] [Related]
12. Cortisol to Dehydroepiandrosterone Sulphate Ratio and Executive Function in Bipolar Disorder.
Tournikioti K; Alevizaki M; Michopoulos I; Mantzou A; Soldatos C; Douzenis A; Dikeos D; Ferentinos P
Neuropsychobiology; 2021; 80(4):342-351. PubMed ID: 33508827
[TBL] [Abstract][Full Text] [Related]
13. Dehydroepiandrosterone, dehydroepiandrosterone-sulfate, and cortisol concentrations in intensive care unit patients.
Folan MM; Stone RA; Pittenger AL; Stoffel JA; Hess MM; Kroboth PD
Crit Care Med; 2001 May; 29(5):965-70. PubMed ID: 11378605
[TBL] [Abstract][Full Text] [Related]
14. Involvement of GABAA receptor modulating neuroactive steroids in patients with social phobia.
Laufer N; Maayan R; Hermesh H; Marom S; Gilad R; Strous R; Weizman A
Psychiatry Res; 2005 Nov; 137(1-2):131-6. PubMed ID: 16226317
[TBL] [Abstract][Full Text] [Related]
15. State and trait related predictors of serum cortisol to DHEA(S) molar ratios and hormone concentrations in schizophrenia patients.
Ritsner M; Gibel A; Maayan R; Ratner Y; Ram E; Modai I; Weizman A
Eur Neuropsychopharmacol; 2007 Mar; 17(4):257-64. PubMed ID: 17107774
[TBL] [Abstract][Full Text] [Related]
16. Differences in blood pregnenolone and dehydroepiandrosterone levels between schizophrenia patients and healthy subjects.
Ritsner M; Maayan R; Gibel A; Weizman A
Eur Neuropsychopharmacol; 2007 Apr; 17(5):358-65. PubMed ID: 17123790
[TBL] [Abstract][Full Text] [Related]
17. Increased circulatory dehydroepiandrosterone and dehydroepiandrosterone-sulphate in first-episode schizophrenia: relationship to gender, aggression and symptomatology.
Strous RD; Maayan R; Lapidus R; Goredetsky L; Zeldich E; Kotler M; Weizman A
Schizophr Res; 2004 Dec; 71(2-3):427-34. PubMed ID: 15474914
[TBL] [Abstract][Full Text] [Related]
18. Association among serum cortisol, dehydroepiandrosterone-sulfate levels and psychiatric symptoms in men with chronic schizophrenia.
Peng R; Li Y
Compr Psychiatry; 2017 Jul; 76():113-118. PubMed ID: 28482249
[TBL] [Abstract][Full Text] [Related]
19. Analysis of neurosteroid levels in attention deficit hyperactivity disorder.
Strous RD; Spivak B; Yoran-Hegesh R; Maayan R; Averbuch E; Kotler M; Mester R; Weizman A
Int J Neuropsychopharmacol; 2001 Sep; 4(3):259-64. PubMed ID: 11602031
[TBL] [Abstract][Full Text] [Related]
20. Dehydroepiandrosterone sulfate (DHEA-S) and psychiatric and laboratory measures of frailty in a residential care population.
Morrison MF; Katz IR; Parmelee P; Boyce AA; TenHave T
Am J Geriatr Psychiatry; 1998; 6(4):277-84. PubMed ID: 9793575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
